col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


56 Results       Page 1

 [1] 
Frontiers Media SA: Frontiers in Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―13 PVC containing silver nanoparticles with antimicrobial properties effective against SARS-CoV-2 Daniel J. da Silva, Guilherme B. Gramcianinov, Pamela Z. Jorge, Vanessa B. Malaquias, Augusto A. Mori, Mário H. Hirata, et al. (+4)
2 [GO] 2023―Feb―07 Qualitative and quantitative determination of chemical constituents in Jinbei oral liquid, a modern Chinese medicine for coronavirus disease 2019, by ultra-performance liquid chromatography coupled with mass spectrometry Aijun Zhang, Qingcui Xu, Juanjuan Jiang, Zimo Zhao, Liangzong Zhang, Kai Tao, et al. (+6)
3 [GO] 2023―Jan―26 Interaction of copper potential metallodrugs with TMPRSS2: A comparative study of docking tools and its implications on COVID-19 Sergio Vazquez-Rodriguez, Diego Ramírez-Contreras, Lisset Noriega, Amalia García-García, Brenda L. Sánchez-Gaytán, Francisco J. Melendez, et al. (+3)
4 [GO] 2023―Jan―24 Computational investigation on the antioxidant activities and on the Mpro SARS-CoV-2 non-covalent inhibition of isorhamnetin Maciej Spiegel, Giada Ciardullo, Tiziana Marino, Nino Russo
5 [GO] 2023―Jan―12 Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity Anasha Kawall, Devin S. M. Lewis, Avini Sharma, Krishna Chavada, Rahul Deshmukh, Srujana Rayalam, et al. (+2)
6 [GO] 2022―Dec―08 Identification of potential inhibitors of omicron variant of SARS-Cov-2 RBD based virtual screening, MD simulation, and DFT Xudong Lü, Cuiyue Feng, Ruijie Lü, Xiyu Wei, Shuai Fan, Maocai Yan, et al. (+3)
7 [GO] 2022―Dec―06 Therapeutic potential of compounds targeting SARS-CoV-2 helicase Matthew T. J. Halma, Mark J. A. Wever, Sanne Abeln, Didier Roche, Gijs J. L. Wuite
8 [GO] 2022―Oct―31 Identification and characterization of alternative sites and molecular probes for SARS-CoV-2 target proteins Suhasini M. Iyengar, Kelly K. Barnsley, Hoang Yen Vu, Ian Jef A. Bongalonta, Alyssa S. Herrod, Jasmine A. Scott, Mary Jo Ondrechen
9 [GO] 2022―Oct―24 Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals Khushboo Bafna, Christopher L. Cioffi, Robert M. Krug, Gaetano T. Montelione
10 [GO] 2022―Oct―11 Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling Toheeb A. Balogun, Onyeka S. Chukwudozie, Uchechukwu C. Ogbodo, Idris O. Junaid, Olugbodi A. Sunday, Oluwasegun M. Ige, et al. (+17)
11 [GO] 2022―Oct―05 Druggable targets and therapeutic development for COVID-19 Xiaohua Duan, Lauretta A. Lacko, Shuibing Chen
12 [GO] 2022―Jul―12 An Efficient Modern Strategy to Screen Drug Candidates Targeting RdRp of SARS-CoV-2 With Potentially High Selectivity and Specificity Haiping Zhang, Xiaohua Gong, Yun Peng, Konda Mani Saravanan, Hengwei Bian, John Z. H. Zhang, et al. (+3)
13 [GO] 2022―Jun―08 Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor Alamgir Khan, Salman Ali Khan, Komal Zia, Mezna Saleh Altowyan, Assem Barakat, Zaheer Ul-Haq
14 [GO] 2022―Apr―26 Inhibitors of SARS-CoV-2 PLpro Dale J. Calleja, Guillaume Lessene, David Komander
15 [GO] 2022―Apr―12 Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors Dale J. Calleja, Nathan Kuchel, Bernadine G. C. Lu, Richard W. Birkinshaw, Theresa Klemm, Marcel Doerflinger, et al. (+19)
16 [GO] 2022―Apr―11 Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease Wiebke Ewert, Sebastian Günther, Francesca Miglioli, Sven Falke, Patrick Y. A. Reinke, Stephan Niebling, et al. (+12)
17 [GO] 2022―Feb―24 Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition Jimmy Lu, Sizhu Amelia Chen, Muhammad Bashir Khan, Raelynn Brassard, Elena Arutyunova, Tess Lamer, et al. (+5)
18 [GO] 2022―Feb―23 Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone Haihai Jiang, Peiyao Yang, Jin Zhang
19 [GO] 2022―Feb―17 An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound Library Shuhua G. Li, Kai S. Yang, Lauren R. Blankenship, Chia-Chuan D. Cho, Shiqing Xu, Hongbin Wang, Wenshe Ray Liu
20 [GO] 2022―Feb―10 Natural Products and Nanotechnology Against Coronavirus Disease 2019 Ning Zeng, Xue Chen, Zeming Liu
21 [GO] 2022―Feb―04 Corrigendum: Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences Shalakha Hegde, Zhichao Tang, Junxing Zhao, Jingxin Wang
22 [GO] 2022―Feb―03 Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development Zongyang Lv, Kristin E. Cano, Lijia Jia, Marcin Drag, Tony T. Huang, Shaun K. Olsen
23 [GO] 2022―Feb―01 In Planta Production of the Receptor-Binding Domain From SARS-CoV-2 With Human Blood Group A Glycan Structures Julia König-Beihammer, Ulrike Vavra, Yun-Ji Shin, Christiane Veit, Clemens Grünwald-Gruber, Yasmin Gillitschka, et al. (+6)
24 [GO] 2021―Dec―28 Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints Marko Jukič, Katarina Kores, Dušanka Janežič, Urban Bren
25 [GO] 2021―Dec―23 Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences Shalakha Hegde, Zhichao Tang, Junxing Zhao, Jingxin Wang
26 [GO] 2021―Nov―19 Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains Yuan Tian, Lisa M. Parsons, Ewa Jankowska, John F. Cipollo
27 [GO] 2021―Oct―10 Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study Anuj Kumar, Dwijesh Chandra Mishra, Ulavappa Basavanneppa Angadi, Rashmi Yadav, Anil Rai, Dinesh Kumar
28 [GO] 2021―Oct―01 Machine Learning of Serum Metabolic Patterns Encodes Asymptomatic SARS-CoV-2 Infection Qiongqiong Wan, Moran Chen, Zheng Zhang, Yu Yuan, Hao Wang, Yanhong Hao, et al. (+3)
29 [GO] 2021―Sep―28 Characterization of Phytochemicals in Ulva intestinalis L. and Their Action Against SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain Seema A. Kulkarni, Sabari B.B. Krishnan, Bavya Chandrasekhar, Kaushani Banerjee, Honglae Sohn, Thirumurthy Madhavan
30 [GO] 2021―Sep―27 Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction Jiacheng Xiong, Yusen Xiang, Ziming Huang, Xiaohong Liu, Mengge Wang, Guangbo Ge, et al. (+4)
31 [GO] 2021―Sep―24 A Linkage-specific Sialic Acid Labeling Strategy Reveals Different Site-specific Glycosylation Patterns in SARS-CoV-2 Spike Protein Produced in CHO and HEK Cell Substrates Qiong Wang, Yan Wang, Shuang Yang, Changyi Lin, Lateef Aliyu, Yiqun Chen, et al. (+6)
32 [GO] 2021―Sep―10 Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19 Adalberto Fernandes Santos, Pedro Póvoa, Paulo Paixão, António Mendonça, Luís Taborda-Barata
33 [GO] 2021―Sep―06 O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins Yong Zhang, Wanjun Zhao, Yonghong Mao, Yaohui Chen, Shanshan Zheng, Wei Cao, et al. (+5)
34 [GO] 2021―Sep―03 Editorial: Molecular Studies of Covid-19 Chemistry Domenica Capasso, Sonia Di Gaetano, Chandrabose Selvaraj, Emilia Pedone
35 [GO] 2021―Jul―22 Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein Bingqian Li, Lin Wang, Huan Ge, Xianglei Zhang, Penxuan Ren, Yu Guo, et al. (+6)
36 [GO] 2021―Jun―24 Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease Juliana C. Ferreira, Samar Fadl, Adrian J. Villanueva, Wael M. Rabeh
37 [GO] 2021―May―10 Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics Shailima Rampogu, Keun Woo Lee
38 [GO] 2021―May―04 Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor Ahmed A. Al-Karmalawy, Mohammed A. Dahab, Ahmed M. Metwaly, Sameh S. Elhady, Eslam B. Elkaeed, Ibrahim H. Eissa, Khaled M. Darwish
39 [GO] 2021―Apr―28 Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs Annalisa Tito, Antonio Colantuono, Luciano Pirone, Emilia Pedone, Daniela Intartaglia, Giuliana Giamundo, et al. (+3)
40 [GO] 2021―Mar―29 Antiviral Essential Oil Components Against SARS-CoV-2 in Pre-procedural Mouth Rinses for Dental Settings During COVID-19: A Computational Study Pradeep Kumar Yadalam, Kalaivani Varatharajan, K. Rajapandian, Priyanka Chopra, Deepavalli Arumuganainar, Thilgavathi Nagarathnam, et al. (+2)
41 [GO] 2021―Mar―12 Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease Hylemariam Mihiretie Mengist, Tebelay Dilnessa, Tengchuan Jin
42 [GO] 2021―Feb―07 In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease Osvaldo Yañez, Manuel Isaías Osorio, Eugenio Uriarte, Carlos Areche, William Tiznado, José M. Pérez-Donoso, et al. (+2)
43 [GO] 2021―Feb―04 In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease Tien Huynh, Wendy Cornell, Binquan Luan
44 [GO] 2021―Jan―21 Computational Characterizations of the Interactions Between the Pontacyl Violet 6R and Exoribonuclease as a Potential Drug Target Against SARS-CoV-2 Rangika Munaweera, Ying S. Hu
45 [GO] 2021―Jan―14 Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease Chandrabose Selvaraj, Umesh Panwar, Dhurvas Chandrasekaran Dinesh, Evzen Boura, Poonam Singh, Vikash Kumar Dubey, Sanjeev Kumar Singh
46 [GO] 2021―Jan―13 Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences Mei Yang, Suhua He, Xiaoxue Chen, Zhaoxia Huang, Ziliang Zhou, Zhechong Zhou, et al. (+3)
47 [GO] 2021―Jan―05 Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations Sugunadevi Sakkiah, Wenjing Guo, Bohu Pan, Zuowei Ji, Gokhan Yavas, Marli Azevedo, et al. (+3)
48 [GO] 2020―Dec―23 Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2 Renata Abel, María Paredes Ramos, Qiaofeng Chen, Horacio Pérez-Sánchez, Flaminia Coluzzi, Monica Rocco, et al. (+6)
49 [GO] 2020―Dec―10 Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins Flavia Squeglia, Maria Romano, Alessia Ruggiero, Giovanni Maga, Rita Berisio
50 [GO] 2020―Dec―08 Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay Eleni Pitsillou, Julia Liang, Katherine Ververis, Kah Wai Lim, Andrew Hung, Tom C. Karagiannis
51 [GO] 2020―Nov―19 Screening of Natural Products Targeting SARS-CoV-2-ACE2 Receptor Interface - A MixMD Based HTVS Pipeline Krishnasamy Gopinath, Elmeri M. Jokinen, Sami T. Kurkinen, Olli T. Pentikäinen
52 [GO] 2020―Nov―16 Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease Pietro Delre, Fabiana Caporuscio, Michele Saviano, Giuseppe Felice Mangiatordi
53 [GO] 2020―Nov―05 Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking Tamer M. Ibrahim, Muhammad I. Ismail, Matthias R. Bauer, Adnan A. Bekhit, Frank M. Boeckler
54 [GO] 2020―Oct―30 Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations Mahmoud A. El Hassab, Aly A. Shoun, Sara T. Al-Rashood, Tarfah Al-Warhi, Wagdy M. Eldehna
55 [GO] 2020―Oct―23 Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain Adriana Carino, Federica Moraca, Bianca Fiorillo, Silvia Marchianò, Valentina Sepe, Michele Biagioli, et al. (+7)
56 [GO] 2020―May―27 Development of Point-of-Care Biosensors for COVID-19 Jane Ru Choi
 [1] 

56 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec